"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.
A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.
Four studies presented at PAINWeek 2016 review the success of abuse-deterrent opioid formulations in stemming abuse and non-medical use.
At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.
A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.
This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.
Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."
New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.
In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.
COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.